ATE212997T1 - Festphasensynthese von oligonucleotid n3'-p5'- phosphoramidaten - Google Patents

Festphasensynthese von oligonucleotid n3'-p5'- phosphoramidaten

Info

Publication number
ATE212997T1
ATE212997T1 AT96919449T AT96919449T ATE212997T1 AT E212997 T1 ATE212997 T1 AT E212997T1 AT 96919449 T AT96919449 T AT 96919449T AT 96919449 T AT96919449 T AT 96919449T AT E212997 T1 ATE212997 T1 AT E212997T1
Authority
AT
Austria
Prior art keywords
dna
oligonucleotide
phosphoramidate
solid phase
phase synthesis
Prior art date
Application number
AT96919449T
Other languages
English (en)
Inventor
Bernard L Hirschbein
Karen L Fearon
Sergei M Gryaznov
Sarah N Mccurdy
Jeffrey S Nelson
Ronald G Schultz
Original Assignee
Lynx Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lynx Therapeutics Inc filed Critical Lynx Therapeutics Inc
Application granted granted Critical
Publication of ATE212997T1 publication Critical patent/ATE212997T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/10—Pyrimidine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/20—Purine radicals with the saccharide radical esterified by phosphoric or polyphosphoric acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Saccharide Compounds (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT96919449T 1996-02-21 1996-06-14 Festphasensynthese von oligonucleotid n3'-p5'- phosphoramidaten ATE212997T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/603,566 US5684143A (en) 1996-02-21 1996-02-21 Oligo-2'-fluoronucleotide N3'->P5' phosphoramidates
PCT/US1996/010418 WO1997031009A1 (en) 1996-02-21 1996-06-14 Solid phase synthesis of oligonucleotide n3'→p5' phosphoramidates

Publications (1)

Publication Number Publication Date
ATE212997T1 true ATE212997T1 (de) 2002-02-15

Family

ID=24415986

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96919449T ATE212997T1 (de) 1996-02-21 1996-06-14 Festphasensynthese von oligonucleotid n3'-p5'- phosphoramidaten

Country Status (7)

Country Link
US (2) US5684143A (de)
EP (1) EP0882059B1 (de)
AT (1) ATE212997T1 (de)
CZ (1) CZ262998A3 (de)
DE (1) DE69619141T2 (de)
PL (1) PL183661B1 (de)
WO (1) WO1997031009A1 (de)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638264B1 (en) 1995-05-16 2003-10-28 Biostratum Incorporation Perfusion apparatus and methods for pharmaceutical delivery
US6342214B1 (en) * 1995-05-16 2002-01-29 Karl Tryggvason Method for viral vector delivery
US9096636B2 (en) 1996-06-06 2015-08-04 Isis Pharmaceuticals, Inc. Chimeric oligomeric compounds and their use in gene modulation
US7812149B2 (en) 1996-06-06 2010-10-12 Isis Pharmaceuticals, Inc. 2′-Fluoro substituted oligomeric compounds and compositions for use in gene modulations
US5898031A (en) 1996-06-06 1999-04-27 Isis Pharmaceuticals, Inc. Oligoribonucleotides for cleaving RNA
US6503711B1 (en) * 1997-06-18 2003-01-07 Ulrich J. Krull Nucleic acid biosensor diagnostics
US6043070A (en) * 1997-08-29 2000-03-28 The Perkin-Elmer Corporation Phosphoramidate-phosphodiester oligonucleotide chimera as primers
EP2392580A1 (de) 1998-02-25 2011-12-07 Emory University 2'-Fluornucleoside
US6087112A (en) 1998-12-30 2000-07-11 Oligos Etc. Inc. Arrays with modified oligonucleotide and polynucleotide compositions
US6958215B1 (en) 1999-03-15 2005-10-25 Geron Corporation Methods and compositions for inhibition of RNA splicing
AU5460700A (en) * 1999-06-04 2000-12-28 Allied-Signal Inc. Protected nucleosides
JP4151751B2 (ja) * 1999-07-22 2008-09-17 第一三共株式会社 新規ビシクロヌクレオシド類縁体
KR100858465B1 (ko) 1999-09-10 2008-09-16 제론 코포레이션 올리고뉴클레오티드 엔3'→피5' 티오포스포라미데이트,이의 합성 및 용도
US6451998B1 (en) 1999-10-18 2002-09-17 Agilent Technologies, Inc. Capping and de-capping during oligonucleotide synthesis
WO2001053307A1 (en) 2000-01-21 2001-07-26 Geron Corporation 2'-arabino-fluorooligonucleotide n3'→p5'phosphoramidates: their synthesis and use
US6881538B1 (en) 2000-03-05 2005-04-19 3M Innovative Properties Company Array comprising diamond-like glass film
US20020137074A1 (en) * 2000-11-21 2002-09-26 Piunno Paul A.E. Selectivity of nucleic acid diagnostic and microarray technologies by control of interfacial nucleic acid film chemistry
US7563618B2 (en) 2001-03-23 2009-07-21 Geron Corporation Oligonucleotide conjugates
AU2003291755A1 (en) 2002-11-05 2004-06-07 Isis Pharmaceuticals, Inc. Oligomers comprising modified bases for binding cytosine and uracil or thymine and their use
US20050085435A1 (en) * 2003-01-02 2005-04-21 Niles Edward G. Novel inhibitors of poxvirus replication
EA014685B1 (ru) 2003-04-25 2010-12-30 Джилид Сайэнс, Инк. Фосфонатсодержащие антивирусные соединения (варианты) и фармацевтическая композиция на их основе
ES2357116T5 (es) 2003-06-02 2021-09-03 Univ Massachusetts Métodos y composiciones para mejorar la eficacia y especificad de FNAi
DK1633767T3 (en) 2003-06-02 2019-03-25 Univ Massachusetts METHODS AND COMPOSITIONS FOR MANAGING THE EFFECT OF RNA SILENCING
JP4690324B2 (ja) 2003-09-09 2011-06-01 ジェロン・コーポレーション テロメラーゼ阻害のための改変オリゴヌクレオチド
WO2005027980A1 (en) 2003-09-12 2005-03-31 University Of Massachusetts Rna interference for the treatment of gain-of-function disorders
WO2005047506A1 (en) 2003-11-04 2005-05-26 Geron Corporation Rna amidates and thioamidates for rnai
EP3427585B1 (de) 2003-11-26 2024-10-16 University of Massachusetts Sequenzspezifische hemmung der kleinen rna-funktion
US8569474B2 (en) 2004-03-09 2013-10-29 Isis Pharmaceuticals, Inc. Double stranded constructs comprising one or more short strands hybridized to a longer strand
AU2005222965B8 (en) 2004-03-15 2010-07-01 City Of Hope Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
US8394947B2 (en) 2004-06-03 2013-03-12 Isis Pharmaceuticals, Inc. Positionally modified siRNA constructs
SI3296312T1 (sl) 2004-07-02 2021-08-31 Geron Corporation Sinteza zaščitenih 3'-amino 5'-fosforamiditnih nukleozidnih monomerov
US7884086B2 (en) 2004-09-08 2011-02-08 Isis Pharmaceuticals, Inc. Conjugates for use in hepatocyte free uptake assays
EP1828217A2 (de) * 2004-12-16 2007-09-05 Febit Biotech GmbH Polymeraseunabhängige analyse der sequenz von polynukleotiden
US7339052B2 (en) * 2005-02-08 2008-03-04 Honeywell International Inc. Phosphoramidite activator for oligonucleotide synthesis
CN101808647A (zh) * 2007-05-15 2010-08-18 海利空医疗公司 通过抑制Gpr12治疗认知障碍的方法
JP5049713B2 (ja) * 2007-09-14 2012-10-17 株式会社コナミデジタルエンタテインメント ゲームシステム並びにこれを構成するゲーム装置及び課題報知装置
WO2009102427A2 (en) 2008-02-11 2009-08-20 Rxi Pharmaceuticals Corp. Modified rnai polynucleotides and uses thereof
WO2010008582A2 (en) 2008-07-18 2010-01-21 Rxi Pharmaceuticals Corporation Phagocytic cell drug delivery system
WO2010033248A2 (en) 2008-09-22 2010-03-25 Rxi Pharmaceuticals Corporation Neutral nanotransporters
US9074211B2 (en) 2008-11-19 2015-07-07 Rxi Pharmaceuticals Corporation Inhibition of MAP4K4 through RNAI
WO2010078536A1 (en) 2009-01-05 2010-07-08 Rxi Pharmaceuticals Corporation Inhibition of pcsk9 through rnai
US9745574B2 (en) 2009-02-04 2017-08-29 Rxi Pharmaceuticals Corporation RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality
GB2468477A (en) 2009-03-02 2010-09-15 Mina Therapeutics Ltd Double stranded RNA molecule comprising siRNA and miRNA precursors
WO2010105096A2 (en) 2009-03-11 2010-09-16 University Of Massachusetts Modulation of human cytomegalovirus replication by micro-rna 132 (mir132), micro-rna 145 (mir145) and micro-rna 212 (mir212)
EP2756845B1 (de) 2009-04-03 2017-03-15 Dicerna Pharmaceuticals, Inc. Verfahren und Zusammensetzungen für spezifische KRAS-Hemmung mit asymmetrischer Doppelstrang-RNA
US9080171B2 (en) 2010-03-24 2015-07-14 RXi Parmaceuticals Corporation Reduced size self-delivering RNAi compounds
KR101852210B1 (ko) 2010-03-24 2018-04-25 알엑스아이 파마슈티칼스 코포레이션 진피 및 섬유증성 적응증에서의 ｒｎａ 간섭
CN103200945B (zh) 2010-03-24 2016-07-06 雷克西制药公司 眼部症候中的rna干扰
WO2012129363A2 (en) 2011-03-24 2012-09-27 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
AU2012340086A1 (en) 2011-11-17 2014-05-29 The Regents Of The University Of California Therapeutic RNA switches compositions and methods of use
US10364455B2 (en) * 2012-09-27 2019-07-30 Bioo Scientific Corporation Methods and compositions for improving removal of ribosomal RNA from biological samples
HK1214293A1 (zh) 2012-10-26 2016-07-22 Geron Corporation C-myc反义寡核苷酸和利用其治疗细胞增殖性疾病的方法
US9228189B2 (en) 2012-10-26 2016-01-05 Geron Corporation C-myc antisense oligonucleotides and methods for using the same to treat cell-proliferative disorders
WO2014113540A1 (en) 2013-01-16 2014-07-24 Iowa State University Research Foundation, Inc. A deep intronic target for splicing correction on spinal muscular atrophy gene
DK3444350T3 (da) 2013-07-03 2022-02-07 Dicerna Pharmaceuticals Inc Fremgangsmåder og sammensætninger til specifik hæmning af alpha-1 antitrypsin ved dobbeltstrenget rna
CN103382212B (zh) * 2013-07-06 2016-08-31 中国科学院成都生物研究所 5′位改性嘌呤霉素化合物及其制备方法和用途
EP3052512A4 (de) * 2013-09-30 2017-02-22 Geron Corporation Phosphorodiamidat-rückgratverbindung für oligonukleotide
WO2015084897A2 (en) 2013-12-02 2015-06-11 Mirimmune, Llc Immunotherapy of cancer
WO2015168108A2 (en) 2014-04-28 2015-11-05 Rxi Pharmaceuticals Corporation Methods for treating cancer using nucleic targeting mdm2 or mycn
JOP20200257A1 (ar) 2014-05-01 2017-06-16 Geron Corp تركيبات أوليجو نوكليوتيد وطرق لتحضيرها
US10900039B2 (en) 2014-09-05 2021-01-26 Phio Pharmaceuticals Corp. Methods for treating aging and skin disorders using nucleic acids targeting Tyr or MMP1
EP3198012B1 (de) 2014-09-26 2019-09-04 University of Massachusetts Rna-modulierende stoffe
WO2016100401A1 (en) 2014-12-15 2016-06-23 Dicerna Pharmaceuticals, Inc. Ligand-modified double-stranded nucleic acids
CA2980337A1 (en) 2015-04-03 2016-10-06 University Of Massachusetts Oligonucleotide compounds for targeting huntingtin mrna
SI3277815T1 (sl) 2015-04-03 2022-01-31 University Of Massachusetts Ologonukleotidne spojine za zdravljenje preeklampsije in drugih angiogeneznih motenj
EP3929293A3 (de) 2015-04-03 2022-03-16 University Of Massachusetts Vollständig stabilisierte asymmetrische sirna
ES2794628T3 (es) 2015-04-15 2020-11-18 Univ Massachusetts Composiciones y métodos para la reactivación de cromosomas XI
EA035885B1 (ru) 2015-04-23 2020-08-27 Джерон Корпорейшн Способы получения полинуклеотидов с использованием композиций солей поливалентных катионов
WO2016183009A2 (en) 2015-05-08 2016-11-17 Dicerna Pharmaceuticals, Inc. Methods and compositions for the specific inhibition of antithrombin 3 (at3) by double-stranded rna
US10808247B2 (en) 2015-07-06 2020-10-20 Phio Pharmaceuticals Corp. Methods for treating neurological disorders using a synergistic small molecule and nucleic acids therapeutic approach
KR20180026739A (ko) 2015-07-06 2018-03-13 알엑스아이 파마슈티칼스 코포레이션 슈퍼옥시드 디스뮤타제 1 (sod1)을 표적화하는 핵산 분자
CN108026575B (zh) 2015-07-17 2022-08-19 哈佛学院董事及会员团体 扩增核酸序列的方法
US10633653B2 (en) 2015-08-14 2020-04-28 University Of Massachusetts Bioactive conjugates for oligonucleotide delivery
WO2017049192A1 (en) 2015-09-17 2017-03-23 University Of Massachusetts Compositions and methods for modulating fmr1 expression
JP2018531037A (ja) 2015-10-19 2018-10-25 アールエックスアイ ファーマシューティカルズ コーポレーション 長い非コードｒｎａを標的とする減少したサイズの自己送達型核酸化合物
US10478503B2 (en) 2016-01-31 2019-11-19 University Of Massachusetts Branched oligonucleotides
US10072261B1 (en) * 2016-03-25 2018-09-11 Agilent Technologies, Inc. Double coupling method for oligonucleotide synthesis
CA3033368A1 (en) 2016-08-12 2018-02-15 University Of Massachusetts Conjugated oligonucleotides
WO2018085842A1 (en) 2016-11-07 2018-05-11 University Of Massachusetts Therapeutic targets for facioscapulohumeral muscular dystrophy
US10443055B2 (en) 2016-12-22 2019-10-15 Beth Israel Deaconess Medical Center Compounds that target MYC microRNA responsive elements for the treatment of MYC-associated cancer
WO2018195355A1 (en) 2017-04-19 2018-10-25 Rxi Pharmaceuticals Corporation Topical delivery of nucleic acid compounds
EP3599844A4 (de) 2017-06-07 2021-01-13 University of Massachusetts Anti-adam33-oligonukleotide und zugehörige verfahren
US10844377B2 (en) 2017-06-23 2020-11-24 University Of Massachusetts Two-tailed self-delivering siRNA
US11306312B2 (en) 2017-09-01 2022-04-19 Thomas Jefferson University Compositions and methods for MYC messenger RNA inhibitors
EP3781677A4 (de) 2018-04-16 2022-01-19 University of Massachusetts Zusammensetzungen und verfahren zur verbesserten geneditierung
KR102916447B1 (ko) 2018-08-10 2026-01-23 유니버시티 오브 매사추세츠 Snp를 표적화하는 변형된 올리고뉴클레오티드
JP7627042B2 (ja) 2018-08-23 2025-02-05 ユニバーシティー オブ マサチューセッツ Ｏ－メチルリッチ完全安定化オリゴヌクレオチド
WO2020150636A1 (en) 2019-01-18 2020-07-23 University Of Massachusetts Dynamic pharmacokinetic-modifying anchors
US11629347B2 (en) 2019-05-06 2023-04-18 University Of Massachusetts Anti-C9ORF72 oligonucleotides and related methods
EP3987024A4 (de) 2019-06-20 2023-11-01 University Of Massachusetts Zusammensetzungen und verfahren zur verbesserten geneditierung
CN114502730A (zh) 2019-08-09 2022-05-13 马萨诸塞大学 经化学修饰的靶向snp的寡核苷酸
US12365894B2 (en) 2019-09-16 2025-07-22 University Of Massachusetts Branched lipid conjugates of siRNA for specific tissue delivery
US20220349006A1 (en) 2019-09-19 2022-11-03 Moderna TX, Inc. Cap guides and methods of use thereof for rna mapping
CN114391043B (zh) 2019-10-25 2024-03-15 昌平国家实验室 哺乳动物dna的甲基化检测及分析
WO2021113773A2 (en) 2019-12-04 2021-06-10 Pai Athma A Identifying non-productive splice sites
AU2020415455A1 (en) 2019-12-23 2022-07-14 University Of Massachusetts Oligonucleotides for tissue specific gene expression modulation
US12312585B2 (en) 2020-02-14 2025-05-27 University Of Massachusetts Oligonucleotides targeting frataxin and related methods
EP4110913A4 (de) 2020-02-28 2024-07-24 University of Massachusetts Oligonukleotide zur prnp-modulation
CN115666659B (zh) 2020-03-26 2026-03-03 马萨诸塞大学 稳定性增加的修饰的寡核苷酸的合成
WO2021195510A1 (en) 2020-03-27 2021-09-30 University Of Massachusetts Dual-acting sirna based modulation of c9orf72
EP4157289A4 (de) 2020-05-26 2024-06-26 University Of Massachusetts Synthetische oligonukleotide mit block- und cluster-modifikationsregionen
US12077758B2 (en) 2020-05-28 2024-09-03 University Of Massachusetts Oligonucleotides for SARS-CoV-2 modulation
KR20240040729A (ko) 2021-06-23 2024-03-28 유니버시티 오브 매사추세츠 자간전증 및 기타 혈관신생 질환의 치료를 위한 최적화된 항-flt1 올리고뉴클레오타이드 화합물
CA3237770A1 (en) 2021-11-10 2023-05-19 University Of Rochester Antisense oligonucleotides for modifying protein expression
EP4444881A2 (de) 2021-11-10 2024-10-16 University of Rochester Auf gata4 abzielende therapeutika zur behandlung von herzhypertrophie
EP4482960A1 (de) 2022-02-25 2025-01-01 Vor Biopharma Inc. Zusammensetzungen und verfahren zur homologiegerichteten reparaturgenmodifizierung
CA3255432A1 (en) 2022-04-04 2023-10-12 Vor Biopharma Inc. COMPOSITIONS AND METHODS OF MEDIATION IN EPITOPE ENGINEERING
US20260049314A1 (en) 2022-08-29 2026-02-19 University Of Rochester Antisense oligonucleotide-based anti-fibrotic therapeutics
WO2025038661A1 (en) * 2023-08-14 2025-02-20 Arrowhead Pharmaceuticals, Inc. Oligonucleotide synthesis methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU187991A (sh) * 1990-12-11 1994-09-09 Hoechst Aktiengesellschaft 3-(2)-amino-ali tiol-modifikovani, s fluorescentnom bojom vezani nukleozidi, nukleotidi i oligonukleotidi, postupak za njihovo dobijanje i njihova upotreba
DE4129318A1 (de) * 1991-09-03 1993-03-04 Bayer Ag Neuartige antisense-oligonukletide mit durchgaengiger phosphoramidat-internukleotidbindung
FI115214B (fi) * 1992-01-22 2005-03-31 Hoechst Ag Menetelmä oligonukleotidianalogien valmistamiseksi ja niiden käyttö
US5476925A (en) * 1993-02-01 1995-12-19 Northwestern University Oligodeoxyribonucleotides including 3'-aminonucleoside-phosphoramidate linkages and terminal 3'-amino groups

Also Published As

Publication number Publication date
US5824793A (en) 1998-10-20
DE69619141D1 (en) 2002-03-21
AU6178996A (en) 1997-09-10
WO1997031009A1 (en) 1997-08-28
CZ262998A3 (cs) 1999-05-12
EP0882059A1 (de) 1998-12-09
PL183661B1 (pl) 2002-06-28
EP0882059B1 (de) 2002-02-06
US5684143A (en) 1997-11-04
PL328639A1 (en) 1999-02-15
AU703509B2 (en) 1999-03-25
DE69619141T2 (de) 2002-09-26

Similar Documents

Publication Publication Date Title
ATE212997T1 (de) Festphasensynthese von oligonucleotid n3'-p5'- phosphoramidaten
DK0691980T3 (da) 7-deazapurinmodifiderende oligonukleotider
DE69734589D1 (de) Antitumor antisense sequenzen gegen h1 und r2 verbindungen von ribonukleotide reductase
MY157626A (en) Method of synthesizing nucleic acid
DE69838449D1 (de) Aminooxy-modifizierte oligonukleotide
WO2004044136A3 (en) Compositions comprising alternating 2’-modified nucleosides for use in gene modulation
EP1013661A4 (de) Bicyclonukleosid- und oligonukleotid-analoga
DK0775149T3 (da) Hidtil ukendte beskyttelsesgrupper og anvendelse heraf i en forbedret fremgangsmåde til oligonukleotidsyntese
DE69521517D1 (de) Prodrug-oligonukleotide
NO963891L (no) Oligonukleotid N3'-> P5' fosforamidater: Synteser og forbindelser; hybridiserings- og nukleaseresistanseegenskaper
CA2132424A1 (en) Antisense oligonucleotide inhibition of papillomavirus
BR9812650A (pt) ácidos nucléicos hibridizando marcação múltipla, preparação dos mesmos, composições, formulação, kits e aplicações
ATE239090T1 (de) Methode zum generieren von einzelsträngigen dna molekülen
CA2084790A1 (en) Endonucleases
BR0015382A (pt) Método para sintetização do ácido nucléico
ATE236916T1 (de) Synthese von oligonukleotiden in lösung
ATE284409T1 (de) Synthese von sulfurierten oligonukleotiden
ATE339434T1 (de) Basenanaloge
Robles et al. A parallel-stranded DNA triplex tethering a Hoechst 33258 analogue results in complex stabilization by simultaneous major groove and minor groove binding
Taniguchi et al. Effects of halogenated WNA derivatives on sequence dependency for expansion of recognition sequences in non-natural-type triplexes
ES2112062T3 (es) Oligonucleotidos con actividad anti-citomegalovirus.
Capaldi et al. Is it essential to use anhydrous acetonitrile in the manufacture of phosphorothioate oligonucleotides?
Murata et al. Modular bent DNAs: A new class of artificial DNAs with a protein binding ability
DK0625194T3 (da) Forøgelse af ribozym-katalytisk aktivitet med et tilstødende facilitator oligonukleotid
ATE318617T1 (de) Synthetische oligonukleotide als erythroid differenzierungserreger